UniProtKB/Swiss-Prot O15151 : Variant p.Thr454Met
Protein Mdm4
Gene: MDM4
Feedback ?
Variant information
Variant position:
454
The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:
LP/P [Disclaimer : Variants classification is intended for research purposes only, not for clinical and diagnostic use . The label disease variant is assigned according to literature reports on probable disease-association that can be based on theoretical reasons. This label must not be considered as a definitive proof for the pathogenic role of a variant. ]
The variants are classified into three categories: LP/P, LB/B and US.LP/P: likely pathogenic or pathogenic. LB/B: likely benign or benign. US: uncertain significance
Residue change:
From Threonine (T) to Methionine (M) at position 454 (T454M, p.Thr454Met).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:
Change from medium size and polar (T) to medium size and hydrophobic (M)
The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:
-1
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another: Lowest score: -4 (low probability of substitution).Highest score: 11 (high probability of substitution). More information can be found on the following page
Variant description:
In BMFS6; altered capacity to interact with MDM2 RING domain in a yeast two-hybrid assay; no effect on ATP binding; expressed at lower levels than wild-type; when expressed in a mouse model, leads to increased TP53 activity, decreased telomerase length and ultimately to bone marrow failure.
Any additional useful information about the variant.
Other resources:
Links to websites of interest for the variant.
Sequence information
Variant position:
454
The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:
490
The length of the canonical sequence.
Location on the sequence:
LKPCSLCEKRPRDGNIIHGR
T GHLVTCFHCARRLKKAGASC
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:
The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human LKPCSLCEKRPRDGNIIHGRT GHLVTCFHCARRLKKAGASC
Mouse LKPCSLCEKRPRDGNIIHGKT SHLTTCFHCARRLKKSGASC
Rat LKPCSLCEKRPRDGNIIHGKT SHLTTCFHCARRLKKSGASC
Bovine LKPCSLCEKRPRNGNIIHGRT GHLVTCFHCARRLKKAGASC
Xenopus laevis LEPCQLCQRRQRNGSVVHGRT AHLVTCFSCACNLKKNQKGC
Zebrafish LEPCKLCRVRPRNGNIIHGRT AHLITCFPCARKLHKFHAPC
Sequence annotation in neighborhood:
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
Chain
1 – 490
Protein Mdm4
Zinc finger
437 – 478
RING-type
Region
393 – 490
Necessary for interaction with USP2
Alternative sequence
109 – 490
LATATTDAAQTLALAQDHSMDIPSQDQLKQSAEESSTSRKRTTEDDIPTLPTSEHKCIHSREDEDLIENLAQDETSRLDLGFEEWDVAGLPWWFLGNLRSNYTPRSNGSTDLQTNQDVGTAIVSDTTDDLWFLNESVSEQLGVGIKVEAADTEQTSEEVGKVSDKKVIEVGKNDDLEDSKSLSDDTDVEVTSEDEWQCTECKKFNSPSKRYCFRCWALRKDWYSDCSKLTHSLSTSDITAIPEKENEGNDVPDCRRTISAPVVRPKDAYIKKENSKLFDPCNSVEFLDLAHSSESQETISSMGEQLDNLSEQRTDTENMEDCQNLLKPCSLCEKRPRDGNIIHGRTGHLVTCFHCARRLKKAGASCPICKKEIQLVIKVFIA -> SASNNTARCNRILQSQKKN. In isoform 2.
Alternative sequence
109 – 490
LATATTDAAQTLALAQDHSMDIPSQDQLKQSAEESSTSRKRTTEDDIPTLPTSEHKCIHSREDEDLIENLAQDETSRLDLGFEEWDVAGLPWWFLGNLRSNYTPRSNGSTDLQTNQDVGTAIVSDTTDDLWFLNESVSEQLGVGIKVEAADTEQTSEEVGKVSDKKVIEVGKNDDLEDSKSLSDDTDVEVTSEDEWQCTECKKFNSPSKRYCFRCWALRKDWYSDCSKLTHSLSTSDITAIPEKENEGNDVPDCRRTISAPVVRPKDAYIKKENSKLFDPCNSVEFLDLAHSSESQETISSMGEQLDNLSEQRTDTENMEDCQNLLKPCSLCEKRPRDGNIIHGRTGHLVTCFHCARRLKKAGASCPICKKEIQLVIKVFIA -> SASNNTDAAQTLALAQDHT. In isoform 3.
Mutagenesis
437 – 437
C -> G. Fails to interact with MDM2.
Beta strand
454 – 459
Literature citations
Germline mutation of MDM4, a major p53 regulator, in a familial syndrome of defective telomere maintenance.
Toufektchan E.; Lejour V.; Durand R.; Giri N.; Draskovic I.; Bardot B.; Laplante P.; Jaber S.; Alter B.P.; Londono-Vallejo J.A.; Savage S.A.; Toledo F.;
Sci. Adv. 6:eaay3511-eaay3511(2020)
Cited for: INVOLVEMENT IN BMFS6; VARIANT BMFS6 MET-454; CHARACTERIZATION OF VARIANT BMFS6 MET-454; FUNCTION; INTERACTION WITH MDM2;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.